Modern technologies have taken biomaterials to another level, but hurdles remain in developing next-generation materials.
With differing cultural attitudes towards tissue donation and transplantation, be prepared for some complex hurdles.
Via partnerships with pharmaceutical companies, Insulet expands its platform technology past insulin delivery.
The rise in chronic disease and the effort to reduce healthcare costs presents a large opportunity for the field of regenerative medicine.
Changing the traditional healthcare model and moving from cure to prevention will take time.
For 3D printing to thrive in the medical device space, the use of biomaterials must be expanded.
Researchers are studying a new biomaterial that helps healthy cells adhere to the implant, fend off bacterial cells and thus, reduce the likelihood of the implant being rejected by the body.